Related references
Note: Only part of the references are listed.Prognostic significance of phospho-histone H3 in prostate carcinoma
Michael Nowak et al.
WORLD JOURNAL OF UROLOGY (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer
B. Turkbey et al.
CLINICAL ONCOLOGY (2013)
Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer
Roopika Menon et al.
JOURNAL OF PATHOLOGY (2013)
14-3-3ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival
Taro Murata et al.
CLINICAL CANCER RESEARCH (2012)
14-3-3 zeta as novel molecular target for cancer therapy
Ajay Matta et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
14-3-3ζ as a prognostic marker and therapeutic target for cancer
Christopher L. Neal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
Veit J. Scheble et al.
MODERN PATHOLOGY (2010)
14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival
Christopher L. Neal et al.
CANCER RESEARCH (2009)
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography - Tandem mass spectrometry
Ajay Matta et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Quality of life and satisfaction with outcome among prostate-cancer survivors
Martin G. Sanda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cellular functions of 14-3-3ζ in apoptosis and cell adhesion emphasize its oncogenic character
M. Niemantsverdriet et al.
ONCOGENE (2008)
Over-expression of 14-3-3zeta is an early event in oral cancer
Ajay Matta et al.
BMC CANCER (2007)
Up-regulation of 14-3-3ζ in lung cancer and its implication as prognostic and therapeutic target
Tao Fan et al.
CANCER RESEARCH (2007)
Overdiagnosis and overtreatment of early detected prostate cancer
C. H. Bangma et al.
WORLD JOURNAL OF UROLOGY (2007)
14-3-3 proteins as potential oncogenes
Guri Tzivion et al.
SEMINARS IN CANCER BIOLOGY (2006)
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: A comparison of the X-ray crystal structures of all human 14-3-3 isoforms
Alexandra K. Gardino et al.
SEMINARS IN CANCER BIOLOGY (2006)
Continued undertreatment of older men with localized prostate cancer
KL Schwartz et al.
UROLOGY (2003)
Longitudinal effects of aging on serum total and free testosterone levels in healthy men
SM Harman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
